Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

NCT06073184 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Atypical Hyperplasia

Interventions

DRUG: Mounjaro
DRUG: Mirena

Sponsor

University Health Network, Toronto